This is a StreetInsider.com Premium Only Page

T2 Biosystems (TTOO) – StreetInsider.com Reports

Apr 11, 2024 04:06 PM T2 Biosystems (TTOO) Shareholders Vote for CRG Debt Conversion into Equity

Mar 28, 2024 09:01 AM T2 Biosystems (TTOO) Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.

Mar 20, 2024 07:32 AM T2 Biosystems (TTOO) Unveils T2Lyme Launch Plans, Provides Business Updates

Mar 18, 2024 09:02 AM T2 Biosystems (TTOO) Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel

Feb 15, 2024 04:03 PM T2 Biosystems (TTOO) Announces Commercial Expansion Through Distributors in Europe and Asia

Feb 12, 2024 09:00 AM T2 Biosystems (TTOO) Granted FDA 510(k) Clearance for the Expanded T2Bacteria Panel

Jan 3, 2024 09:01 AM T2 Biosystems (TTOO) Announces FDA 510(k) Submission to Expand Use of the FDA-Cleared T2Candida Panel to Include Pediatric Testing

Nov 1, 2023 09:01 AM T2 Biosystems (TTOO) Regains Nasdaq Compliance

Oct 23, 2023 09:01 AM T2 Biosystems (TTOO) Announces Amendment and Extension of CRG Term Loan Agreement

Oct 12, 2023 04:09 PM T2 Biosystems (TTOO) announces preliminary Q3 total revenue of $1.5 million

Oct 12, 2023 04:02 PM T2 Biosystems (TTOO) Announces FDA 510(k) Submission to Expand the Pathogen Detection on its FDA-Cleared T2Bacteria Panel for Detection of Acinetobacter baumannii

Oct 12, 2023 09:03 AM T2 Biosystems (TTOO) Announces Reverse Stock Split Effective Today

Sep 19, 2023 09:00 AM T2 Biosystems (TTOO) Receives FDA 510(k) Clearance for the T2Biothreat Panel

Aug 24, 2023 08:36 AM T2 Biosystems (TTOO) Announces 141.6M Share Offering by Selling Stockholders

Aug 24, 2023 08:35 AM T2 Biosystems (TTOO) Files to Offer 142M Shares of Common Stock

Aug 9, 2023 08:30 AM T2 Biosystems (TTOO) Regains Nasdaq Compliance

Jul 31, 2023 08:30 AM T2 Biosystems (TTOO) Receives Extension to Comply with Nasdaq Listing Requirements

Jul 20, 2023 08:33 AM T2 Biosystems (TTOO) Receives FDA Breakthrough Device Designation for Candida Auris Diagnostic Test

Jul 14, 2023 03:13 PM T2 Biosystems, Inc (TTOO) PT Lowered to $0.12 at Canaccord Genuity

Jul 12, 2023 08:30 AM T2 Biosystems (TTOO) Reports Prelim Q2 Revenue of $2M

Jun 9, 2023 09:15 AM T2 Biosystems (TTOO) Announces Clinical Collaboration with Vanderbilt University Medical Center to Implement and Evaluate the T2Bacteria Panel for Clinical Use

Jun 5, 2023 09:01 AM T2 Biosystems (TTOO) Announces Submission for FDA Breakthrough Device Designation for Candida Auris Diagnostic Test

May 30, 2023 09:03 AM T2 Biosystems (TTOO) Announces Second Largest Sepsis-Driven Instrument Sale in Company History

May 24, 2023 07:56 AM T2 Biosystems, Inc (TTOO) PT Lowered to $0.20 at Canaccord Genuity

May 23, 2023 04:36 PM U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.69%

May 23, 2023 08:02 AM T2 Biosystems (TTOO) Announces Exploration of Strategic Alternatives, Cuts 30% Staff

May 23, 2023 08:01 AM T2 Biosystems (TTOO) Announces FDA 510(k) Submission for the T2Biothreat Panel

May 23, 2023 07:55 AM T2 Biosystems (TTOO) Halted, News Pending

Mar 14, 2023 07:26 AM T2 Biosystems, Inc (TTOO) PT Lowered to $0.50 at Canaccord Genuity

Feb 15, 2023 04:47 PM U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.11%

Feb 15, 2023 07:30 AM T2 Biosystems (TTOO) Prices 11.11M Share Offering at $1.08/sh

Feb 13, 2023 04:20 PM T2 Biosystems (TTOO) Announces Proposed Public Offering

Feb 13, 2023 04:02 PM T2 Biosystems (TTOO) Reports Positive Results upon Completion of US Clinical Evaluation for the T2Biothreat Panel

Jan 23, 2023 04:30 PM T2 Biosystems (TTOO) Reports Prelim Q4 and FY22 Results

Dec 28, 2022 09:00 AM T2 Biosystems (TTOO) Announces Extension of Multiyear Innovative Technology Contract with Vizient, Inc.

Dec 8, 2022 08:28 AM T2 Biosystems (TTOO) Highlights Peer-Reviewed Article Linking COVID-19 and Sepsis and Underscoring CDC Call for Adoption of Early and Accurate Microbial Diagnosis to Guide Targeted Initial Antimicrobi

Dec 6, 2022 11:21 AM T2 Biosystems (TTOO) Granted U.S. Patent Related to Rapid Detection Of Bacteria

Nov 1, 2022 08:33 AM T2 Biosystems (TTOO) Regains Compliance with Nasdaq’s Minimum Bid Price Rule

Oct 20, 2022 09:05 AM T2 Biosystems (TTOO) Initiates Studies to Add Acinetobacter Baumannii to the FDA-Cleared T2Bacteria Panel

Oct 14, 2022 08:31 AM T2 Biosystems (TTOO) Highlights Multiple New Studies Demonstrating Improved Rapid Detection Across Several Patient Populations

Oct 13, 2022 04:30 PM Canaccord Genuity Downgrades T2 Biosystems, Inc (TTOO) to Hold

Oct 13, 2022 09:01 AM T2 Biosystems (TTOO) Announces Plan to Commercialize a Diagnostic Test for Early Lyme Disease

Oct 12, 2022 08:35 AM T2 Biosystems (TTOO) Announces Preliminary Third Quarter 2022 Financial Results and Updates 2022 Financial Outlook

Sep 29, 2022 08:36 AM T2 Biosystems (TTOO) Announces BARDA Exercise of Contract Option 3 Valued at $3.7 Million

Sep 22, 2022 04:15 PM T2 Biosystems (TTOO) Announces Commercial Expansion Through Distributor in Baltic Region

Aug 15, 2022 04:12 PM T2 Biosystems (TTOO) Misses Q2 EPS by 1c

Aug 9, 2022 08:33 AM T2 Biosystems (TTOO) to Explore Potential to Develop Rapid Molecular Diagnostic Test for Monkeypox Virus

Jul 18, 2022 04:21 PM T2 Biosystems (TTOO) Granted EU Patent for Methods for Amplification in Complex Samples - Patent Grants

Jul 11, 2022 08:05 AM T2 Biosystems (TTOO) Granted FDA Breakthrough Device Designation for the T2Lyme Panel

Jul 11, 2022 08:05 AM T2 Biosystems (TTOO) Granted FDA Breakthrough Device Designation for the T2Lyme Panel